VKH
BBH icon

Virtu KCG Holdings’s VanEck Biotech ETF BBH Stock Holding History

Virtu KCG Holdings’s Portfolio BBH Stock Details BBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-2,242
Closed -$267K – 2887
2017
Q1 		$267K Sell
2,242
-2,141
-49% -$250K 0.01% 2080
2016
Q4 		$471K Buy
+4,383
New +$477K 0.01% 1560
2016
Q3 		– Sell
-6,610
Closed -$676K – 3064
2016
Q2 		$676K Sell
6,610
-344
-5% -$36.7K 0.01% 1073
2016
Q1 		$721K Sell
6,954
-4,874
-41% -$508K 0.02% 852
2015
Q4 		$1.5M Sell
11,828
-5,523
-32% -$677K 0.03% 554
2015
Q3 		$1.98M Buy
+17,351
New +$2.3M 0.03% 456
2015
Q2 		– Sell
-15,236
Closed -$1.97M – 3318
2015
Q1 		$1.97M Buy
+15,236
New +$1.91M 0.04% 382
2014
Q3 		– Sell
-14,873
Closed -$1.42M – 3576
2014
Q2 		$1.42M Sell
14,873
-19,527
-57% -$1.75M 0.02% 816
2014
Q1 		$3.13M Buy
+34,400
New +$3.34M 0.04% 446

Other funds holding BBH

AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
MCM
Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return
SFS
Strategic Financial Services Utica, New York $2.1B AUM 19.14% 1-Year Est. Return
BRM
Boston Research & Management Manchester, Massachusetts $421M AUM 16.18% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
AL
Aspiriant LLC Los Angeles, California $4.05B AUM 19.01% 1-Year Est. Return

Virtu KCG Holdings's BBH Position: Q2 2017 in Review

Virtu KCG Holdings sold out of VanEck Biotech ETF (BBH) in Q2 2017, closing a stake of 2,242 shares — an estimated $267K sold.

Virtu KCG Holdings first reported a position in BBH in Q1 2014 and held it in 9 quarters. The position peaked at $3.13M in Q1 2014. 83 funds tracked by Wall St. Rank hold BBH as of Q2 2017.

  • Virtu KCG Holdings reported no remaining VanEck Biotech ETF position as of Q2 2017 after selling out during the quarter.
  • Virtu KCG Holdings sold 2,242 VanEck Biotech ETF shares in Q2 2017, an estimated $267K.
  • Virtu KCG Holdings first reported a position in VanEck Biotech ETF in Q1 2014 and held it in 9 quarters.
  • Virtu KCG Holdings's VanEck Biotech ETF position peaked at $3.13M in Q1 2014.
  • 83 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.